Postmenopausal testosterone therapy and breast cancer risk

Maturitas

Volumn 49, Issue 4, 2004, Pages 267-275

  Somboonporn, Woraluk ^a   Davis, Susan R ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Breast cancer; Menopause; Testosterone therapy

Indexed keywords

AROMATASE; ESTROGEN; GESTAGEN; TESTOSTERONE;

APOPTOSIS; AROMATIZATION; BIOAVAILABILITY; BREAST CARCINOMA; CANCER RISK; CELL PROLIFERATION; DISEASE ASSOCIATION; ENZYME ACTIVATION; EPITHELIUM; HUMAN; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MEDICAL RESEARCH; MENOPAUSAL SYNDROME; MITOGENESIS; NONHUMAN; OVARY POLYCYSTIC DISEASE; REVIEW;

ANIMALIA;

EID: 8644236707     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.06.020     Document Type: Article

References (81)

1. E. Simpson, G. Rubin, C. Clyne, K. Robertson, L. O'Donnell, and M. Jones The role of local estrogen biosynthesis in males and females Trends Endocrinol. Metab. 11 5 2000 184 188
2. H.G. Burger, J. Hailes, M. Menelaus, J. Nelson, B. Hudson, and N. Balazs The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results Maturitas 6 4 1984 351 358
3. H.G. Burger, J. Hailes, J. Nelson, and M. Menelaus Effect of combined implants of estradiol and testosterone on libido in postmenopausal women Br. Med. J. 294 1987 936 937
4. S.R. Davis, P. McCloud, B.J. Strauss, and H. Burger Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality Maturitas 21 3 1995 227 236
5. B.B. Sherwin, and M.M. Gelfand Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause Am. J. Obstet. Gynecol. 151 2 1985 153 160
6. B.B. Sherwin, M.M. Gelfand, and W. Brender Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in surgical menopause Psychosom. Med. 47 4 1985 339 351
7. B.B. Sherwin Use of combined estrogen-androgen preparations in the postmenopause: evidence from clinical studies Int. J. Fertil. Womens Med. 43 2 1998 98 103
8. B.B. Sherwin Randomized clinical trials of combined estrogen-androgen preparations: effects on sexual functioning Fertil. Steril. 77 Suppl. 4 2002 49 54
9. J.L. Shifren, G. Braunstein, J. Simon, P. Casson, J.E. Buster, and R.E. Red Burki Transdermal testosterone treatment in women with impaired sexual function after oophorectomy N. Eng. J. Med. 343 10 2000 682 688
10. R.T. Chlebowski, S.L. Hendrix, R.D. Langer, M.L. Stefanick, M. Gass, and D. Lane Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial J. Am. Med. Assoc. 289 24 2003 3243 3253
11. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial J. Am. Med. Assoc. 288 3 2002 321 333
12. H.G. Burger Androgen production in women Fertil. Steril. 77 4 2002 3 5
13. E.R. Simpson Aromatization of androgens in women: current concepts and findings Fertil. Steril. 77 4 2002 6 10
14. W.H. Cleland, C.R. Mendelson, and E.R. Simpson Effects of aging and obesity on aromatase activity of human adipose cells J. Clin. Endocrinol. Metab. 60 1 1985 174 177
15. S.E. Bulun, and E.R. Simpson Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome p450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age J. Clin. Endocrinol. Metab. 78 2 1994 428 432
16. J. Wei, H. Xu, J.L. Davies, and G.P. Hemmings Increase of plasma IL-6 concentration with age in healthy subjects Life Sci. 51 25 1992 1953 1956
17. W.R. McKane, S. Khosla, J.M. Peterson, K. Egan, and B.L. Riggs Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women J. Bone Miner. Res. 9 8 1994 1313 1318
18. C. Longcope, and S. Baker Androgen and estrogen dynamics: relationships with age, weight, and menopausal status J. Clin. Endocrinol. Metab. 76 3 1993 601 604
19. W. Yue, L.M. Berstein, J.P. Wang, G.M. Clark, C.J. Hamilton, and L.M. Demers The potential role of estrogen in aromatase regulation in the breast J. Steroid Biochem. Mol. Biol. 79 1-5 2001 157 164
20. J. Nakamura, Q. Lu, G. Aberdeen, E. Albrecht, and A. Brodie The effect of estrogen on aromatase and vascular endothelial growth factor messenger ribonucleic acid in the normal nonhuman primate mammary gland J. Clin. Endocrinol. Metab. 84 4 1999 1432 1437
21. L.M. Berstein, A.A. Larionov, A.S. Kyshtoobaeva, K.M. Pozharisski, V.F. Semiglazov, and O.A. Ivanova Aromatase in breast cancer tissue - localization and relationship with reproductive status of patients J. Cancer Res. Clin. Oncol. 122 8 1996 495 498
22. P. Bolufer, E. Ricart, A. Lluch, C. Vazquez, A. Rodriguez, and A. Ruiz Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis staging J. Clin. Oncol. 10 3 1992 438 446
23. J.R. Pasqualini, G. Chetrite, C. Blacker, M.C. Feinstein, L. Delalonde, and M. Talbi Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients J. Clin. Endocrinol. Metab. 81 4 1996 1460 1464
24. D.L. Cassidenti, R.J. Paulson, P. Serafini, F.Z. Stanczyk, and R.A. Lobo Effects of sex steroids on skin 5 alpha-reductase activity in vitro Obstet. Gynecol. 78 1 1991 103 107
25. P.C. Serafini, J. Catalino, and R.A. Lobo The effect of spironolactone on genital skin 5 alpha-reductase activity J. Steroid Biochem. 23 2 1985 191 194
26. P. Serafini, and R.A. Lobo Prolactin modulates peripheral androgen metabolism Fertil. Steril. 45 1 1986 41 46
27. M. Krieg, A. Schlenker, and K.D. Voigt Inhibition of androgen metabolism in stroma and epithelium of the human benign prostatic hyperplasia by progesterone, estrone, and estradiol Prostate 6 3 1985 233 240
28. F. Kuttenn, C. Rigaud, F. Wright, and P. Mauvais-Jarvis Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol J. Clin. Endocrinol. Metab. 51 5 1980 1107 1111
29. H.J. Dean, and J.S. Winter The effect of five synthetic progestational compounds on 5 alpha-reductase activity in genital skin fibroblast monolayers Steroids 43 1 1984 13 24
30. R.B. Clarke, I.J. Laidlaw, L.J. Jones, A. Howell, and E. Anderson Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status Br. J. Cancer 67 3 1993 606 611
31. R.B. Clarke, A. Howell, and E. Anderson Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression Breast Cancer Res. Treat. 45 2 1997 121 133
32. I.J. Laidlaw, R.B. Clarke, A. Howell, A.W. Owen, C.S. Potten, and E. Anderson The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone Endocrinology 136 1 1995 164 171
33. N. Kyprianou, H.F. English, N.E. Davidson, and J.T. Isaacs Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation Cancer Res. 51 1 1991 162 166
34. R.R. Perry, Y. Kang, and B. Greaves Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells Ann. Surg. Oncol. 2 3 1995 238 245
35. S. Ando, F. De Amicis, V. Rago, A. Carpino, M. Maggioloini, and M. Panno Breast cancer: from estrogen to androgen receptor Mol. Cell Endocrinol. 193 2002 121 125
36. G. Boccuzzi, E. Brignardello, M. Di Monaco, V. Gatto, L. Leonardi, and A. Pizzini 5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol Br. J. Cancer 70 6 1994 1035 1039
37. J. Ortmann, S. Prifti, M.K. Bohlmann, S. Rehberger-Schneider, T. Strowitzki, and T. Rabe Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines Gynecol. Endocrinol. 16 2 2002 113 120
38. J.H. MacIndoe, and L.A. Etre An antiestrogenic action of androgens in human breast cancer cells J. Clin. Endocrinol. Metab. 53 4 1981 836 842
39. S.N. Birrell, J.M. Bentel, T.E. Hickey, C. Ricciardelli, M.A. Weger, and D.J. Horsfall Androgens induce divergent proliferative responses in human breast cancer cell lines J. Steroid Biochem. Mol. Biol. 52 5 1995 459 467
40. J. Herrmann, E. Bruckheimer, and T. McDonnell Cell death signal transduction and bcl-2 function Biochem. Soc. Trans. 24 1996 1059 1065
41. B. Xie, S.W. Tsao, and Y.C. Wong Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens Carcinogenesis 20 8 1999 1597 1606
42. J. Lapointe, A. Fournier, V. Richard, and C. Labrie Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells Endocrinology 140 1 1999 416 421
43. M. Kandouz, A. Lombet, J.Y. Perrot, D. Jacob, S. Carvajal, and A. Kazem Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells J. Steroid Biochem. Mol. Biol. 69 1-6 1999 463 471
44. S.N. Birrell, D.M. Roder, D.J. Horsfall, J.M. Bentel, and W.D. Tilley Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression J. Clin. Oncol. 13 7 1995 1572 1577
45. B. Xie, S.W. Tsao, and Y.C. Wong Sex hormone-induced mammary carcinogenesis in the female Noble rats: expression of bcl-2 and bax in hormonal mammary carcinogenesis Breast Cancer Res. Treat. 61 1 2000 45 57
46. M.J. Jayo, T.C. Register, C.L. Hughes, U. Blas-Machado, E. Sulistiawati, and H. Borgerink Effects of an oral contraceptive combination with or without androgen on mammary tissues: a study in rats J. Soc.. Gynecol. Invest. 7 4 2000 257 265
47. J. Zhou, S. Ng, O. Adesanya-Famuiya, K. Anderson, and C.A. Bondy Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression FASEB J. 14 12 2000 1725 1730
48. C. Dimitrakakis, J. Zhou, J. Wang, A. Belanger, F. Labrie, and C. Cheng A physiologic role for testosterone in limiting estrogenic stimulation of the breast Menopause 10 4 2003 292 298
49. S. Dauvois, S.M. Li, C. Martel, and F. Labrie Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat Breast Cancer Res. Treat. 14 3 1989 299 306
50. S. Dauvois, C.S. Geng, C. Levesque, Y. Merand, and F. Labrie Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice Cancer Res. 51 12 1991 3131 3135
51. G. Secreto, P. Toniolo, and P. Pisani Androgens and breast cancer in premenopausal women Cancer Res. 49 1989 471 476
52. H. Yu, X.O. Shu, R. Shi, Q. Dai, F. Jin, and Y.T. Gao Plasma sex steroid hormones and breast cancer risk in Chinese women Int. J. Cancer. 105 1 2003 92 97
53. D.K. Wysowski, G.W. Comstock, K.J. Helsing, and H.L. Lau Sex hormone levels in serum in relation to the development of breast cancer Am. J. Epidemiol. 125 5 1987 791 799
54. H.V. Thomas, T.J. Key, D.S. Allen, J.W. Moore, M. Dowsett, and I.S. Fentiman A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey Br. J. Cancer 75 7 1997 1075 1079
55. R. Fox, E. Corrigan, P.G. Thomas, and M.G. Hull Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries Br. J. Obstet. Gynaecol. 98 3 1991 294 299
56. C.B. Coulam, J.F. Annegers, and J.S. Kranz Chronic anovulation syndrome and associated neoplasia Obstet. Gynecol. 61 4 1983 403 407
57. K.E. Anderson, T.A. Sellers, P.L. Chen, S.S. Rich, C.P. Hong, and A.R. Folsom Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa Cancer 79 3 1997 494 499
58. M.D. Gammon, and W.D. Thompson Polycystic ovaries and the risk of breast cancer Am. J. Epidemiol. 134 8 1991 818 824
59. L. Lipworth, H.O. Adami, D. Trichopoulos, K. Carlstrom, and C. Mantzoros Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer Epidemiology 7 1 1996 96 100
60. G. Secreto, P. Toniolo, and E. Berrino Serum and urinary androgens and risk of breast cancer in postmenopausal women Cancer Res. 51 1991 2572 2576
61. C.F. Garland, N.J. Friedlander, E. Barrett-Connor, and K.T. Khaw Sex hormones and postmenopausal breast cancer: a prospective study in an adult community Am. J. Epidemiol. 135 11 1992 1220 1230
62. F. Berrino, P. Muti, A. Michelli, G. Bolelli, V. Krogh, and R. Sciajno Serum sex hormone levels after menopause and subsequent breast cancer J. Natl. Cancer Inst. 88 1996 291 291
63. J.F. Dorgan, C. Longcope, H.E. Stephenson Jr., R.T. Falk, R. Miller, and C. Franz Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk Cancer Epidemiol. Biomarkers Prev. 5 7 1996 533 539
64. H.V. Thomas, T.J. Key, D.S. Allen, J.W. Moore, M. Dowsett, and I.S. Fentiman A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey Br. J. Cancer 76 3 1997 401 405
65. A. Zeleniuch-Jacquotte, P.F. Bruning, J. Bonfrer, K. Koenig, R. Shore, and M. Kim Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women Am. J. Epidemiol. 145 11 1997 1030 1038
66. S.E. Hankinson, W.C. Willett, J.E. Manson, G.A. Colditz, D.J. Hunter, and D. Spiegelman Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women J. Natl. Cancer Inst. 90 1998 1292 1299
67. J.A. Cauley, F.L. Lucas, L.H. Kuller, K. Stone, W. Browner, and S.R. Cummings Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group Ann. Intern. Med. 130 4 pt 1 1999 270 277
68. J. Manjer, R. Johansson, G. Berglund, L. Janzon, R. Kaaks, and A. Agren Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden) Cancer Causes Control 14 7 2003 599 607
69. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies, J Natl Cancer Inst 2002;94(8):606-16.
70. E. Barrett-Connor, N.J. Friedlander, and K.T. Khaw Dehydroepiandrosterone sulfate and breast cancer risk Cancer Res. 50 20 1990 6571 6574
71. G.G. Klee, and D. Heser Techniques to measure testosterone in the elderly Mayo Clin. Proc. 75 2000 S19 S25
72. M. Ewertz Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Demnark Int. J. Cancer 42 1988 832 838
73. L.A. Brinton, R. Hoover, and J.F. Fraumeni Jr. Menopausal oestrogens, and breast cancer risk: an expanded study case-control study Br. J. Cancer 54 1986 825 832
74. Dimitrakakis C, Jones R, Liu A, Bondy C. Breast cancer incidence in Australian women using testosterone in addition to estrogen replacement. In: Proceedings of the 85th Annual Meeting of the Endocrine Society. Philadelphia, MD: The Endocrine Society Press; 2003.
75. G.A. Bachmann, J. Bancroft, G. Braunstein, H. Burger, S.R. Davis, and L. Dennerstein Female androgen insufficiency: the Princeton Consensus Statement on definition, classification and assessment Fertil. Steril. 77 660 2002 665
76. B.B. Sherwin Affective changes with estrogen and androgen replacement therapy in surgically menopausal women J. Affect Disord. 14 2 1988 177 187
77. G. Bachmann, J. Bancroft, G. Braunstein, H. Burger, S. Davis, and L. Dennerstein Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment Fertil. Steril. 77 4 2002 660 665
78. D. Forman, D. Stockton, H. Moller, M. Quinn, P. Babb, and R. De Angelis Cancer prevalence in the UK: results from the EUROPREVAL study Ann. Oncol. 14 4 2003 648 654
79. B.K. Edwards, H.L. Howe, L.A. Ries, M.J. Thun, H.M. Rosenberg, and R. Yancik Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden Cancer 94 10 2002 2766 2792
80. V. Beral Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 9382 2003 419 427
81. T.J. Hopkins Oestrogen only arm of women's health initiative trial is stopped BMJ 328 7440 2004 602